DKSH Partners With Korea Ginseng Corporation to Bring the Premium Red Ginseng CheongKwanJang to Thailand, Singapore, and Malaysia
DKSH has been appointed by Korea Ginseng Corporation (KGC), a worldwide renowned ginseng manufacturer, to exclusively distribute and market Korea’s leading red ginseng brand CheongKwanJang, to Thailand, Singapore, and Malaysia. This agreement is in line with DKSH Business Unit Healthcare’s strategic focus of strengthening its regional footprint.
Bangkok, Thailand, March 21, 2023 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an exclusive agreement with Korea Ginseng Corporation (KGC), a worldwide leading ginseng producer, to bring CheongKwanJang – Korea’s most prominent red ginseng brand with a tradition over 120 years – to Thailand, Singapore, and Malaysia.
Under the agreement, DKSH will provide full Market Expansion Services by building dedicated sales and marketing teams on the ground and managing logistics and product distribution. DKSH’s experienced teams and broad distribution network will ensure red ginseng CheongKwanJang reaches those who seek to improve their health and well-being. The products will be made available in modern trade, traditional trade, convenience stores, specialty stores, and e-commerce channels across these markets thanks to DKSH’s omni-channel approach.
CheongKwanJang is Korea’s leading red ginseng brand. Through 120 years of manufacturing know-how and strict quality control, KGC prides itself on the craftsmanship that has upheld the reputation of Korean ginseng for thousands of years through various products and services for those seeking well-being and health remedy.
Each of the CheongKwanJang products is certified by the Republic of Korea’s Ministry of Food and Science to feature only premium ginseng extract, from the roots of plants that have been allowed to mature for the full six years required for optimal results.
Bangkok, Thailand, March 21, 2023 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an exclusive agreement with Korea Ginseng Corporation (KGC), a worldwide leading ginseng producer, to bring CheongKwanJang – Korea’s most prominent red ginseng brand with a tradition over 120 years – to Thailand, Singapore, and Malaysia.
Under the agreement, DKSH will provide full Market Expansion Services by building dedicated sales and marketing teams on the ground and managing logistics and product distribution. DKSH’s experienced teams and broad distribution network will ensure red ginseng CheongKwanJang reaches those who seek to improve their health and well-being. The products will be made available in modern trade, traditional trade, convenience stores, specialty stores, and e-commerce channels across these markets thanks to DKSH’s omni-channel approach.
CheongKwanJang is Korea’s leading red ginseng brand. Through 120 years of manufacturing know-how and strict quality control, KGC prides itself on the craftsmanship that has upheld the reputation of Korean ginseng for thousands of years through various products and services for those seeking well-being and health remedy.
Each of the CheongKwanJang products is certified by the Republic of Korea’s Ministry of Food and Science to feature only premium ginseng extract, from the roots of plants that have been allowed to mature for the full six years required for optimal results.
Bin An, Global Business Head, Korea Ginseng Corporation, said: “At KGC, we strive to make people’s lives better every day by providing them with the best, traditionally harvested, most carefully selected Korean red ginseng products. With DKSH’s expertise and proven track record in market expansion in Asia Pacific, we are confident to have a trusted partner who will help us realize our vision of strengthening growth in ASEAN markets while providing high-quality Korean red ginseng to improve the health of people in Thailand, Singapore, and Malaysia.
Bijay Singh, Head of Business Unit Healthcare at DKSH, added: “We are committed to enriching people’s lives and making healthcare accessible for all. The partnership with Korea Ginseng Corporation strengthens our ambition to become the preferred partner for clients to help people in Asia have better access to high-quality healthcare products. It is our honor to be able to support KGC’s brand mission, and we are fully committed to driving business growth for KGC in these three key ASEAN markets, while reaching greater heights together.”
About Korea Ginseng Corporation
Established in 1899 as a government organization, Korea Ginseng Corporation is a highly trusted and reliable company within the category. As the oldest and most reputable manufacturer, KGC provides various products and services with its strict quality control for healthier and happier life for the people all around the world. Led by ‘Korean Red Ginseng brand CheongKwanJang, the world's number one ginseng brand (Euromonitor 2022)’, KGC's family of brands include Good Base, Koreselect and Donginbi. KGC has successfully maintained its proud legacy and tradition with the state of an art production facility and R&D centers. KGC will continue to strive and lead the expansion of global ginseng market based on scientific research of ginseng’s efficacy using modern technology.
For more information visit, https://kgc.co.kr/en/index.do
About DKSH DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,990 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2022. www.dksh.com/hec
Bijay Singh, Head of Business Unit Healthcare at DKSH, added: “We are committed to enriching people’s lives and making healthcare accessible for all. The partnership with Korea Ginseng Corporation strengthens our ambition to become the preferred partner for clients to help people in Asia have better access to high-quality healthcare products. It is our honor to be able to support KGC’s brand mission, and we are fully committed to driving business growth for KGC in these three key ASEAN markets, while reaching greater heights together.”
About Korea Ginseng Corporation
Established in 1899 as a government organization, Korea Ginseng Corporation is a highly trusted and reliable company within the category. As the oldest and most reputable manufacturer, KGC provides various products and services with its strict quality control for healthier and happier life for the people all around the world. Led by ‘Korean Red Ginseng brand CheongKwanJang, the world's number one ginseng brand (Euromonitor 2022)’, KGC's family of brands include Good Base, Koreselect and Donginbi. KGC has successfully maintained its proud legacy and tradition with the state of an art production facility and R&D centers. KGC will continue to strive and lead the expansion of global ginseng market based on scientific research of ginseng’s efficacy using modern technology.
For more information visit, https://kgc.co.kr/en/index.do
About DKSH DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,990 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2022. www.dksh.com/hec
No comments